Bleakley Financial Group, LLC
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 1936953
PARSIPPANY, NJ
Position in PBH
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$725,761
-$52,581 QoQ
Shares Held
12,245
-2.9% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bleakley Financial Group, LLC holds $14,751,437 across 10 Drug Manufacturers - Specialty & Generic names. PBH ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
431,602 | $7,993,269 | |
| 2 | ZTS |
Zoetis Inc.
|
18,748 | $2,216,201 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
13,951 | $1,058,183 | |
| 4 | LQDA |
Liquidia Corp
|
22,855 | $862,547 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
12,245 | $725,761 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
135,767 | $563,433 | |
| 7 | HROW |
Harrow, Inc.
|
13,183 | $464,832 | |
| 8 | ALKS |
Alkermes plc.
|
10,064 | $355,863 |
All Filings in PBH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $725,761 | 12,245 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $778,342 | 12,617 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $680,908 | 10,912 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||